Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Retinitis Pigmentosa by Wharton's Jelly Derived Mesenchymal Stem Cells: Preliminary Clinical Results

NCT04224207 is registered in ClinicalTrials.gov with Ankara Universitesi Teknokent as lead sponsor.

NCT NCT04224207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Retinitis Pigmentosa by Wharton's Jelly Derived Mesenchymal Stem Cells: Preliminary Clinical Results
Lead sponsor
Ankara Universitesi Teknokent
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2019
Completion date
January 1, 2020
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inherited retinal dystrophy, retinitis pigmentosa